202 related articles for article (PubMed ID: 25155252)
1. Compartment differences of inflammatory activity in chronic obstructive pulmonary disease.
Ji J; von Schéele I; Bergström J; Billing B; Dahlén B; Lantz AS; Larsson K; Palmberg L
Respir Res; 2014 Aug; 15(1):104. PubMed ID: 25155252
[TBL] [Abstract][Full Text] [Related]
2. Levels of IL-32 in Serum, Induced Sputum Supernatant, and Bronchial Lavage Fluid of Patients with Chronic Obstructive Pulmonary Disease.
Gasiuniene E; Lavinskiene S; Sakalauskas R; Sitkauskiene B
COPD; 2016 Oct; 13(5):569-75. PubMed ID: 27018873
[TBL] [Abstract][Full Text] [Related]
3. Interleukin-18 in induced sputum: association with lung function in chronic obstructive pulmonary disease.
Rovina N; Dima E; Gerassimou C; Kollintza A; Gratziou C; Roussos C
Respir Med; 2009 Jul; 103(7):1056-62. PubMed ID: 19208460
[TBL] [Abstract][Full Text] [Related]
4. Effects of active smoking on airway and systemic inflammation profiles in patients with chronic obstructive pulmonary disease.
Pelegrino NR; Tanni SE; Amaral RA; Angeleli AY; Correa C; Godoy I
Am J Med Sci; 2013 Jun; 345(6):440-5. PubMed ID: 22874622
[TBL] [Abstract][Full Text] [Related]
5. Comparison of biomarkers in serum and induced sputum of patients with occupational asthma and chronic obstructive pulmonary disease.
Kleniewska A; Walusiak-Skorupa J; Piotrowski W; Nowakowska-Świrta E; Wiszniewska M
J Occup Health; 2016 Jul; 58(4):333-9. PubMed ID: 27265531
[TBL] [Abstract][Full Text] [Related]
6. Smoking status and anti-inflammatory macrophages in bronchoalveolar lavage and induced sputum in COPD.
Kunz LI; Lapperre TS; Snoeck-Stroband JB; Budulac SE; Timens W; van Wijngaarden S; Schrumpf JA; Rabe KF; Postma DS; Sterk PJ; Hiemstra PS;
Respir Res; 2011 Mar; 12(1):34. PubMed ID: 21426578
[TBL] [Abstract][Full Text] [Related]
7. Comparison of inflammatory markers in induced and spontaneous sputum in a cohort of COPD patients.
Tangedal S; Aanerud M; Persson LJ; Brokstad KA; Bakke PS; Eagan TM
Respir Res; 2014 Nov; 15(1):138. PubMed ID: 25398249
[TBL] [Abstract][Full Text] [Related]
8. Increased levels of the chemokines GROalpha and MCP-1 in sputum samples from patients with COPD.
Traves SL; Culpitt SV; Russell RE; Barnes PJ; Donnelly LE
Thorax; 2002 Jul; 57(7):590-5. PubMed ID: 12096201
[TBL] [Abstract][Full Text] [Related]
9. Vascular endothelial growth factor: an angiogenic factor reflecting airway inflammation in healthy smokers and in patients with bronchitis type of chronic obstructive pulmonary disease?
Rovina N; Papapetropoulos A; Kollintza A; Michailidou M; Simoes DC; Roussos C; Gratziou C
Respir Res; 2007 Jul; 8(1):53. PubMed ID: 17631682
[TBL] [Abstract][Full Text] [Related]
10. Potential prognostic value of biomarkers in lavage, sputum and serum in a five year clinical follow-up of smokers with and without COPD.
Holz O; Waschki B; Roepcke S; Watz H; Lauer G; Faulenbach C; Hohlfeld JM
BMC Pulm Med; 2014 Mar; 14():30. PubMed ID: 24581181
[TBL] [Abstract][Full Text] [Related]
11. Comparison of induced sputum with bronchial wash, bronchoalveolar lavage and bronchial biopsies in COPD.
Rutgers SR; Timens W; Kaufmann HF; van der Mark TW; Koëter GH; Postma DS
Eur Respir J; 2000 Jan; 15(1):109-15. PubMed ID: 10678630
[TBL] [Abstract][Full Text] [Related]
12. Responsiveness of blood and sputum inflammatory cells in Japanese COPD patients, non-COPD smoking controls, and non-COPD nonsmoking controls.
Kawayama T; Kinoshita T; Matsunaga K; Kobayashi A; Hayamizu T; Johnson M; Hoshino T
Int J Chron Obstruct Pulmon Dis; 2016; 11():295-303. PubMed ID: 26929615
[TBL] [Abstract][Full Text] [Related]
13. Extracellular cadmium in the bronchoalveolar space of long-term tobacco smokers with and without COPD and its association with inflammation.
Sundblad BM; Ji J; Levänen B; Midander K; Julander A; Larsson K; Palmberg L; Lindén A
Int J Chron Obstruct Pulmon Dis; 2016; 11():1005-13. PubMed ID: 27274222
[TBL] [Abstract][Full Text] [Related]
14. Differences in interleukin-8 and tumor necrosis factor-alpha in induced sputum from patients with chronic obstructive pulmonary disease or asthma.
Keatings VM; Collins PD; Scott DM; Barnes PJ
Am J Respir Crit Care Med; 1996 Feb; 153(2):530-4. PubMed ID: 8564092
[TBL] [Abstract][Full Text] [Related]
15. Patterns of airway inflammation and MMP-12 expression in smokers and ex-smokers with COPD.
Babusyte A; Stravinskaite K; Jeroch J; Lötvall J; Sakalauskas R; Sitkauskiene B
Respir Res; 2007 Nov; 8(1):81. PubMed ID: 18001475
[TBL] [Abstract][Full Text] [Related]
16. The effect of induced sputum and bronchoalveolar lavage fluid from patients with chronic obstructive pulmonary disease on neutrophil migration in vitro.
Babusyte A; Jeroch J; Stakauskas R; Stravinskaite K; Malakauskas K; Sakalauskas R
Medicina (Kaunas); 2010; 46(5):315-22. PubMed ID: 20679746
[TBL] [Abstract][Full Text] [Related]
17. Repeatability of and relationship between potential COPD biomarkers in bronchoalveolar lavage, bronchial biopsies, serum, and induced sputum.
Röpcke S; Holz O; Lauer G; Müller M; Rittinghausen S; Ernst P; Lahu G; Elmlinger M; Krug N; Hohlfeld JM
PLoS One; 2012; 7(10):e46207. PubMed ID: 23056262
[TBL] [Abstract][Full Text] [Related]
18. Leptin as local inflammatory marker in COPD.
Broekhuizen R; Vernooy JH; Schols AM; Dentener MA; Wouters EF
Respir Med; 2005 Jan; 99(1):70-4. PubMed ID: 15672852
[TBL] [Abstract][Full Text] [Related]
19. Airway inflammatory markers in chronic obstructive pulmonary disease patients and healthy smokers.
Hacievliyagil SS; Mutlu LC; Temel İ
Niger J Clin Pract; 2013; 16(1):76-81. PubMed ID: 23377476
[TBL] [Abstract][Full Text] [Related]
20. Elevated MMP-12 protein levels in induced sputum from patients with COPD.
Demedts IK; Morel-Montero A; Lebecque S; Pacheco Y; Cataldo D; Joos GF; Pauwels RA; Brusselle GG
Thorax; 2006 Mar; 61(3):196-201. PubMed ID: 16308335
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
